Circulating messenger RNA profiling with microarray and next-generation sequencing: Cross-platform comparison

Cancer Genomics and Proteomics

Volumn 12, Issue 5, 2015, Pages 223-230

  Shih, Chun Liang ^a   Luo, Ji Dung ^a,b   Chang, John Wen Cheng ^c,d   Chen, Tai Long ^a,b   Chien, Yu Tzu ^b   Yu, Chia Jung ^a   Chiou, Chiuan Chian ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Circulating mRNA; DASL assay; RNA sequencing; Transcriptomic profiling

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; MESSENGER RNA; TRANSCRIPTOME;

ARTICLE; CANCER PATIENT; CASE REPORT; CDNA MEDIATED ANNEALING SELECTION EXTENSION, AND LIGATION ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HIGH THROUGHPUT SEQUENCING; HUMAN; NEXT GENERATION SEQUENCING; NON SMALL CELL LUNG CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; BLOOD; CASE CONTROL STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; PROCEDURES; REPRODUCIBILITY; STANDARDS;

CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84943246071     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Santiago-Dieppa DR, Steinberg J, Gonda D, Cheung VJ, Carter BS and Chen CC: Extracellular vesicles as a platform for 'liquid biopsy' in glioblastoma patients. Expert Rev Mol Diagn 14: 819-825, 2014.
2. Crowley E, Di Nicolantonio F, Loupakis F and Bardelli A: Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol 10: 472-484, 2013.
3. Pirola CJ, Fernandez Gianotti T, Castano GO, Mallardi P, San Martino J, Mora Gonzalez Lopez Ledesma M, Flichman D, Mirshahi F, Sanyal AJ and Sookoian S: Circulating microRNA signature in non-alcoholic fatty liver disease: from serum noncoding RNAs to liver histology and disease pathogenesis. Gut 64: 800-812, 2015.
4. Enache LS, Enache EL, Ramiere C, Diaz O, Bancu L, Sin A and Andre P: Circulating RNA molecules as biomarkers in liver disease. Int J Mol Sci 15: 17644-17666, 2014.
5. Baraniskin A, Nopel-Dunnebacke S, Ahrens M, Jensen SG, Zollner H, Maghnouj A, Wos A, Mayerle J, Munding J, Kost D, Reinacher-Schick A, Liffers S, Schroers R, Chromik AM, Meyer HE, Uhl W, Klein-Scory S, Weiss FU, Stephan C, Schwarte-Waldhoff I, Lerch MM, Tannapfel A, Schmiegel W, Andersen CL and Hahn SA: Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer 132: E48-57, 2013.
6. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW and Fasching PA: Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 7: e29770, 2012.
7. Dong L, Qi P, Xu MD, Ni SJ, Huang D, Xu QH, Weng WW, Tan C, Sheng WQ, Zhou XY and Du X: Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls. Int J Cancer 137: 1128-1135, 2015.
8. Lim SH, Becker TM, Chua W, Caixeiro NJ, Ng WL, Kienzle N, Tognela A, Lumba S, Rasko JE, de Souza P and Spring KJ: Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer. Cancer Lett 346: 24-33, 2014.
9. Gutnick J, Soldes O, Gupta M and Milas M: Circulating thyrotropin receptor messenger RNA for evaluation of thyroid nodules and surveillance of thyroid cancer in children. J Pediatr Surg 47: 171-176, 2012.
10. Ramlau R, Thomas M, Novello S, Plummer R, Reck M, Kaneko T, Lau MR, Margetts J, Lunec J, Nutt J and Scagliotti GV: Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker. Clin Lung Cancer 2015.
11. Abramovitz M, Barwick BG, Willis S, Young B, Catzavelos C, Li Z, Kodani M, Tang W, Bouzyk M, Moreno CS and Leyland-Jones B: Molecular characterisation of formalin-fixed paraffinembedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform. Br J Cancer 105: 1574-1581, 2011.
12. Abramovitz M, Ordanic-Kodani M, Wang Y, Li Z, Catzavelos C, Bouzyk M, Sledge GW Jr. Moreno CS and Leyland-Jones B: Optimization of RNA extraction from FFPE tissues for expression profiling in the DASL assay. Biotechniques 44: 417-423, 2008.
13. Kojima K, April C, Canasto-Chibuque C, Chen X, Deshmukh M, Venkatesh A, Tan PS, Kobayashi M, Kumada H, Fan JB and Hoshida Y: Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classification. PLoS One 9: e86961, 2014.
14. Ton CC, Vartanian N, Chai X, Lin MG, Yuan X, Malone KE, Li CI, Dawson A, Sather C, Delrow J, Hsu L and Porter PL: Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation. Breast Cancer Res Treat 125: 879-883, 2011.
15. Morton ML, Bai X, Merry CR, Linden PA, Khalil AM, Leidner RS and Thompson CL: Identification of mRNAs and lincRNAs associated with lung cancer progression using next-generation RNA sequencing from laser micro-dissected archival FFPE tissue specimens. Lung Cancer 85: 31-39, 2014.
16. Semenov DV, Baryakin DN, Brenner EV, Kurilshikov AM, Vasiliev GV, Bryzgalov LA, Chikova ED, Filippova JA, Kuligina EV and Richter VA: Unbiased approach to profile the variety of small non-coding RNA of human blood plasma with massively parallel sequencing technology. Expert Opin Biol Ther 12(Suppl 1): S43-51, 2012.
17. Chen HH, Lai PF, Lan YF, Cheng CF, Zhong WB, Lin YF, Chen TW and Lin H: Exosomal ATF3 RNA attenuates proinflammatory gene MCP-1 transcription in renal ischemiareperfusion. J Cell Physiol 229: 1202-1211, 2014.
18. Lasser C: Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors. Expert Opin Biol Ther 12(Suppl 1): S189-197, 2012.
19. Kuhlmann JD, Wimberger P, Wilsch K, Fluck M, Suter L and Brunner G: Increased level of circulating U2 small nuclear RNA fragments indicates metastasis in melanoma patients. Clin Chem Lab Med 53: 605-611, 2015.
20. Zhang X, Zhang Z, Dai F, Shi B, Chen L, Zhang X, Zang G, Zhang J, Chen X, Qian F, Hu Y and Yuan Z: Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C. PLoS One 9: e92112, 2014.
21. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L: Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7: 562-578, 2012.
22. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P and Mesirov JP: GenePattern 2.0. Nat Genet 38: 500-501, 2006.
23. Stewart DJ: Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst 106: djt356, 2014.
24. Oyama T, Sugio K, Isse T, Matsumoto A, Nose N, Uramoto H, Nozoe T, Morita M, Kagawa N, Osaki T, Muto M, Yasumoto K and Kawamoto T: Expression of cytochrome P450 in non-small cell lung cancer. Front Biosci 13: 5787-5793, 2008.
25. Javid J, Mir R, Julka PK, Ray PC and Saxena A: Extracellular cytochrome c as a biomarker for monitoring therapeutic efficacy and prognosis of non-small cell lung cancer patients. Tumour Biol 36: 4253-4260, 2015.
26. Schuller HM: Impact of neuro-psychological factors on smoking-associated lung cancer. Cancers (Basel) 6: 580-594, 2014.
27. Aydiner A, Ciftci R, Karabulut S and Kilic L: Does beta-blocker therapy improve the survival of patients with metastatic non-small cell lung cancer? Asian Pac J Cancer Prev 14: 6109-6114, 2013.
28. Sanz G, Leray I, Dewaele A, Sobilo J, Lerondel S, Bouet S, Grebert D, Monnerie R, Pajot-Augy E and Mir LM: Promotion of cancer cell invasiveness and metastasis emergence caused by olfactory receptor stimulation. PLoS One 9: e85110, 2014.